Court of Justice of the European Union · EU
Judgment of the Court (Third Chamber), 12 December 2013.#Eli Lilly and Company Ltd v Human Genome Sciences Inc.#Request for a preliminary ruling from the High Court of Justice (England and Wales), Chancery Division (Patents Court).#Medicinal products for human use — Supplementary protection certificate — Regulation (EC) No 469/2009 — Article 3 — Conditions for obtaining such a certificate — Concept of a ‘product protected by a basic patent in force’ — Criteria — Wording of the claims of the basic patent — Precision and specificity — Functional definition of an active ingredient — Structural definition of an active ingredient — European Patent Convention.#Case C‑493/12.
- Identifier
- CELEX 62012CJ0493
- Status
- decided
- Decided
- 12 December 2013
- Official source
- https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:62012CJ0493
- Source provider
- eurlex
- Retrieved
- 2026-08-27T15:05:39.131Z
Identifier
- CELEX: 62012CJ0493
Direct relationships
No labelled cross-repository relations yet.